113 related articles for article (PubMed ID: 16619543)
1. Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours.
Lo Muzio L; Campisi G; Farina A; Rubini C; Ferrari F; Falaschini S; Leonardi R; Carinci F; Stalbano S; De Rosa G
Anticancer Res; 2006; 26(2B):1343-9. PubMed ID: 16619543
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
3. Effect of p63 expression on survival in oral squamous cell carcinoma.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
[TBL] [Abstract][Full Text] [Related]
4. Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults.
Choi KK; Kim MJ; Yun PY; Lee JH; Moon HS; Lee TR; Myoung H
Oral Oncol; 2006 Feb; 42(2):208-17. PubMed ID: 16249114
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma.
Mese H; Sasaki A; Nakayama S; Yoshioka N; Yoshihama Y; Kishimoto K; Matsumura T
Oncol Rep; 2002; 9(2):341-4. PubMed ID: 11836604
[TBL] [Abstract][Full Text] [Related]
6. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
8. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
[TBL] [Abstract][Full Text] [Related]
10. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.
Arduino PG; Carrozzo M; Chiecchio A; Broccoletti R; Tirone F; Borra E; Bertolusso G; Gandolfo S
J Oral Maxillofac Surg; 2008 Aug; 66(8):1570-9. PubMed ID: 18634942
[TBL] [Abstract][Full Text] [Related]
12. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
[TBL] [Abstract][Full Text] [Related]
13. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation.
Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
[TBL] [Abstract][Full Text] [Related]
16. Salvage treatment for recurrent oral squamous cell carcinoma.
Sun GW; Tang EY; Yang XD; Hu QG
J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
[TBL] [Abstract][Full Text] [Related]
17. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
19. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Cancer; 2008 Jan; 112(1):94-103. PubMed ID: 18022917
[TBL] [Abstract][Full Text] [Related]
20. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
